- Mots-clés > availability of quality, safe and effective medical products
- Mots-clés > central purchasing agency for supply
- Mots-clés > distribution - central warehouses to service delivery points (SDPs)
- Mots-clés > medical supply management
- Mots-clés > medicines supply systems
- Mots-clés > pharmaceutical supply chain
- Mots-clés > price negotiations
- Mots-clés > procurement - national systems
- Mots-clés > procurement and supply management (PSM)
- Mots-clés > selection of medicines
(2015; 108 pages)
NMSF, 2015. Reform of the National Health Supply Chain in Sudan: Achievements, Challenges, Success Factors and Lessons learned. 2nd Edition. National Medical Supplies Fund, Khartoum Sudan.
The National Medical Supplies Fund (NMSF), the successor of the Central Medical Supplies Public Corporation (CMS) is the national centre for procurement and distribution of medicines in Sudan. NMSF has implemented a comprehensive reform programme started in 2011. This report aims to describe the changes that have taken place in the NMSF’s medicine supply system. These changes include a number of initiatives to improve geographical, physical and economical accessibility to quality medicines and other health commodities. Investing US$ 27 million to establish NMSF branches in 14 states in 2014, e-procurement, online sales, purchasing of registered medicines, restrict supply of medicines mainly to governmental health organizations are examples of the initiatives that have been pursued during the reform period. The study was based on document research to present the progress in the implementations of the reform. Bids that occurred before (2008) and after (2011) the reform have been used for comparison to measure the impact of the reform on procurement. The time to ﬁnalize the bidding process, the total cost of the purchased quantities, the number of medicines with market authorization, sources of medicines, failure rate of quality testing, the rate of expiration, and the availability of medicines were evaluated. Implementing the NMSF’s reform has improved the availability of quality of medicines without increasing the costs and therefore achieved its objective: the value for money.